BenQ Medical Technology Corp.
TTPEX:411640.10
TWD
0.00
(0.00%)
ISIN
TW0004116009
Return %
Stock
S&P 500
1Y
-15.67
14.20
3Y
-28.52
81.12
5Y
49.07
68.34
Capital Structure
TWD
•
in mil. unless spec.Working Capital
TWD
•
in mil. unless spec.Growth Rates
TWD
•
in mil. unless spec.Quarterly Revenue
TWD
•
in mil. unless spec.Quarterly Earnings Per Share
TWD
•
in mil. unless spec.Quarterly Dividends Per Share
TWD
•
in mil. unless spec.Company Description
- CEO
- Hsin Pao Kuan
- Full Time Employees
- 405
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- No. 46, Zhouzi Street Taipei TPE Taiwan 11493
- IPO Date
- Jan 2, 2002
- Website
- benqmedicaltech.com
- Similar Companies
- Business
- BenQ Medical Technology Corporation (4116.TWO), a subsidiary of Qisda Corporation, manufactures, assembles, maintains, repairs, wholesales, retails, leases and sells medical equipment, consumables and related services; core offerings encompass operating room equipment including electric and manual hydraulic surgical tables, adjustable and single color temperature surgical lights, pendant medical supply units and ICU suspension bridges; diagnostic tools such as portable and cart-based ultrasound systems, diagnostic and surgical medical display monitors, magnetic resonance displays and AI-enabled rehabilitation equipment for long-term care; integrated solutions like the IQOR operating system and neurosurgical navigation robots; medical disposables featuring needle-free IV infusion and anesthesia products including volume metric administration sets, connectors and laryngeal mask airways (LMA), surgical and endoscopy disposables, endoscopic treatment instruments, hemodialyzers, plasmapheresis-related products and blood bags; and medical services comprising pharmaceuticals and consumables integrated supply, equipment leasing, hospital management consulting, hearing services, dietary supplements via brick-and-mortar channels, veterinary drugs and equipment supply chains, clinical laboratory operations, and digital orthodontic materials including whitening trays, braces and mouthguards. The company operates primarily in Taiwan, Mainland China, Thailand, Indonesia and over 50 countries worldwide, with manufacturing sites in Taiwan and China, an R&D center in Taiwan, and sales/service centers across its key markets; it was founded in 1989 as Trident Medical Corp., renamed BenQ Medical Technology Corporation in June 2011, went public in 2015 and is headquartered in Taipei, Taiwan. Recent developments include a March 2025 strategic partnership with Brain Navi Biotechnology to commercialize the NaoTrac neurosurgical navigation robot in China, leveraging BenQ's hospital network and aligning with China's 14th Five-Year Plan for medical equipment; acquisition of K2 International Medical boosting Southeast Asian revenue growth; establishment of new subsidiary KANG YUE MEDICAL CO., LTD.; Shanghai factory certification for surgical lights and tables in Q4 2025 with production line setup for neurosurgical robots; expansion of 3D spinal navigation robots into India and domestic veterinary rehabilitation; addition of endoscopic equipment/consumables, chemotherapy drug dispensing systems and enhanced product lines in Thailand/Indonesia; and entry into clinical laboratories and veterinary supply chains, driving 12% year-over-year revenue growth to NTD 3.9 billion in the first three quarters of 2025.